ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 117 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $10,440,000 | -40.6% | 500,000 | -72.2% | 0.03% | -49.1% |
| Q1 2020 | $17,586,000 | +52.7% | 1,800,000 | +80.0% | 0.05% | +89.3% |
| Q4 2019 | $11,520,000 | +111.4% | 1,000,000 | 0.0% | 0.03% | +115.4% |
| Q3 2019 | $5,450,000 | -84.7% | 1,000,000 | -66.7% | 0.01% | -85.4% |
| Q2 2019 | $35,670,000 | +126.9% | 3,000,000 | 0.0% | 0.09% | +128.2% |
| Q1 2019 | $15,720,000 | +66.3% | 3,000,000 | 0.0% | 0.04% | +50.0% |
| Q4 2018 | $9,450,000 | -47.9% | 3,000,000 | 0.0% | 0.03% | -35.0% |
| Q3 2018 | $18,150,000 | -14.4% | 3,000,000 | -25.0% | 0.04% | -18.4% |
| Q2 2018 | $21,200,000 | +4.4% | 4,000,000 | +14.3% | 0.05% | +4.3% |
| Q1 2018 | $20,300,000 | +132.0% | 3,500,000 | +40.0% | 0.05% | +135.0% |
| Q4 2017 | $8,750,000 | +19.9% | 2,500,000 | +25.0% | 0.02% | +11.1% |
| Q3 2017 | $7,300,000 | +46.0% | 2,000,000 | 0.0% | 0.02% | +50.0% |
| Q2 2017 | $5,000,000 | – | 2,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 5,068,233 | $17,739,000 | 5.88% |
| Sonic Fund II, L.P. | 6,552,068 | $22,932,000 | 1.69% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $1,680,000 | 0.88% |
| Avoro Capital Advisors LLC | 6,950,000 | $24,325,000 | 0.42% |
| RTW INVESTMENTS, LP | 7,357,917 | $25,753,000 | 0.39% |
| K2 PRINCIPAL FUND, L.P. | 898,307 | $3,144,000 | 0.26% |
| Artal Group S.A. | 3,000,000 | $10,500,000 | 0.21% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,827,000 | $9,895,000 | 0.18% |
| WS MANAGEMENT LLLP | 307,442 | $1,076,000 | 0.11% |
| ALGERT GLOBAL LLC | 82,145 | $288,000 | 0.10% |